pharma · Advanced Cancer · Non-small Cell Lung Cancer · RCUS
Arcus Biosciences
Arcus Biosciences clinical programs — 21 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3928 Point Eden Way, Hayward, California 94545, US
- Founded
- 2015
- Employees
- 655
- Programs
- 53
- Drugs
- 25
- Patents
- 30
Arcus Biosciences projects
21 ClinicalTrials.gov programs sponsored by Arcus Biosciences.
Arcus Biosciences has 21 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AB680
Arcus Biosciences
Metastatic Colorectal Cancer
1 trial -
ARC-21(EDGE-Gastric)
Arcus Biosciences
Upper Gastrointestinal Tract Cancer, Advanced Upper Gastrointestinal Tract Malignancies, Gastrointestinal Tract Malignancies
1 trial -
ARC-9
Arcus Biosciences
Metastatic colorectal cancer
1 trial -
Atezolizumab
Arcus Biosciences
Prostate Adenocarcinoma
1 trial -
Casdatifan
Arcus Biosciences
Renal Cell Carcinoma
1 trial -
Domvanalimab
Arcus Biosciences
Advanced Non-Small Cell Lung Cancer
1 trial -
Domvanalimab
Arcus Biosciences
Gastrointestinal Tract Malignancies
1 trial -
Domvanalimab
Arcus Biosciences
Head and Neck Squamous Cell Carcinoma
1 trial -
Domvanalimab
Arcus Biosciences
Non Small Cell Lung Cancer
2 trials -
Etrumadenant
Arcus Biosciences
Prostatic Neoplasms, Castration-Resistant
1 trial -
Etrumadenant (AB928)
Arcus Biosciences
Rectal Cancer
1 trial -
Fluorouracil
Arcus Biosciences
Borderline Resectable Pancreatic Adenocarcinoma
1 trial -
Gemcitabine
Arcus Biosciences
Biliary Tract Carcinoma
1 trial -
Quemliclustat
Arcus Biosciences
Oligometastatic Prostate Cancer
1 trial -
SRF617
Arcus Biosciences
Metastatic Castration-resistant Prostate Cancer
1 trial -
ZIMBERELIMAB
Arcus Biosciences
Pancreatic Cancer
1 trial -
Zimberelimab
Arcus Biosciences
Adenocarcinoma Stomach
1 trial -
Zimberelimab
Arcus Biosciences
Hepatobiliary Cancer
1 trial -
Zimberelimab
Arcus Biosciences
Melanoma
1 trial -
Zimberelimab
Arcus Biosciences
Pancreatic Ductal Adenocarcinoma
1 trial -
Zimberelimab (ZIM)
Arcus Biosciences
Lung Cancer
1 trial
Frequently asked questions
How many clinical projects does Arcus Biosciences have?
21 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.